The 23rd China International Medical Device Design and Manufacturing Technology (Autumn) Exhibition (ICMD) was grandly held at the Shenzhen Convention and Exhibition Center from August 30th to September 1st, Witleaf still maintains the corporate image of "professional and dedicated" that display the company's powerful core technology to client.
During the exhibition, the company's position was crowded with customers who came to visit and consult. The company separately displayed key technology modules for high-performance monitoring, including respiratory gas monitoring module, blood oxygen monitoring module, blood pressure monitoring module, ECG monitoring and diagnosis module, invasive pressure monitoring module, cardiac output monitoring module, EEG monitoring module, and integrated multi-parameter module, the latest products: exercise ECG test system and vital sign monitor, etc., solutions for various monitoring products, electronic blood pressure Meter, high-performance portable oximeter, etc. The company's key technology modules for monitoring have received high attention from professional customers in the industry, and have reached cooperation intentions with many clients on the spot.
Witleaf is committed to the research of key monitoring technologies. The respiratory gas monitoring module technology displayed at this exhibition has been at the leading level in the industry. The gas modules that have been released and widely used include mainstream end-respiratory carbon dioxide modules, side stream end-respiratory carbon dioxide modules, and more Gas monitoring modules (CO2, N20, 02).During the exhibition, customers spoke highly of the high-performance respiratory gas monitoring modules. At present, the company is focusing on developing anesthetic gas monitoring module, which can simultaneously monitor five anesthetic gases (enflurane, isoflurane, desflurane, sevoflurane, halothane), as well as carbon dioxide and nitrous oxide. The release will be completed at the beginning of 2017 and will fill the gap in domestic autonomous anesthetic gas monitoring technology.
The company's exercise ECG test system (16-lead ECG, non-invasive blood pressure monitoring) exhibited to customers the company's strong technical strength in the key technical fields of ECG monitoring and diagnosis. Once exhibited, its powerful ECG diagnostic algorithm technology and high level of signal quality won unanimous praise from customers!
In the future, the company will continue to conduct in-depth research in the field of core monitoring technology, and continue to provide customers with professional, high-quality, and efficient technology and product services!
